Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Type 2 diabetes mellitus (T2DM)-related cognitive decline is associated with neuroimaging changes. However, only a few studies have focused on early functional alteration in T2DM prior to mild cognitive impairment (MCI). This study aimed to investigate the early changes of global connectivity patterns in T2DM by using a resting-state functional magnetic resonance imaging (rs-fMRI) technique. Thirty-four T2DM subjects and 38 age-, sex-, and education-matched healthy controls (HCs) underwent rs-fMRI in a 3T MRI scanner. Degree centrality (DC) was used to identify the functional hubs of the whole brain in T2DM without MCI. Then the functional connectivity (FC) between hubs and the rest of the brain was assessed by using the hub-based approach. Compared with HCs, T2DM subjects showed increased DC in the right cerebellum lobules III-V. Hub-based FC analysis found that the right cerebellum lobules III-V of T2DM subjects had increased FC with the right cerebellum crus II and lobule VI, the right temporal inferior/middle gyrus, and the right hippocampus. Increased DC in the right cerebellum regions III-V, as well as increased FC within cerebellar regions and ipsilateral cerebrocerebellar regions, may indicate an important pathophysiological mechanism for compensation in T2DM without MCI.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7533640PMC
http://dx.doi.org/10.3389/fneur.2020.01016DOI Listing

Publication Analysis

Top Keywords

t2dm subjects
12
increased cerebellum
12
functional hubs
8
type diabetes
8
diabetes mellitus
8
mild cognitive
8
cognitive impairment
8
t2dm mci
8
subjects increased
8
cerebellum lobules
8

Similar Publications

Objective:  Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder frequently associated with obesity, leading to increased risks of cardiovascular and renal complications. Dapagliflozin, a sodium-glucose cotransporter-2 (SGLT2) inhibitor, has emerged as a promising therapeutic agent for improving glycemic control and promoting weight reduction. However, evaluating its safety and efficacy in obese T2DM patients remains essential, particularly in real-world clinical settings.

View Article and Find Full Text PDF

US eligibility and preventable cardiovascular disease events from semaglutide in type 2 diabetes.

Diab Vasc Dis Res

September 2025

Mary and Steve Wen Cardiovascular Division, School of Medicine, University of California, Irvine, CA, USA.

BackgroundThe SUSTAIN-6 trial showed the cardiovascular disease (CVD) benefits of semaglutide among patients with type 2 diabetes mellitus (T2DM). We estimated the US population eligibility and preventable CVD events from semaglutide.MethodsUS adults with T2DM were selected from the National Health and Nutrition Examination Survey 2011-2020 based on SUSTAIN-6 eligibility criteria.

View Article and Find Full Text PDF

HDL remodeling and enrichment with apoCIII and apoE in Indigenous Australians.

J Clin Lipidol

August 2025

ANZAC Research institute, Concord Repatriation General Hospital and University of Sydney, Sydney, NSW, Australia (Drs Kockx, Wang, and Kritharides); Department of Cardiology, Concord Repatriation General Hospital, Sydney Local Health District and University of Sydney, Sydney, NSW, Australia (Dr Krit

Background: Indigenous Australians have an increased risk of type 2 diabetes mellitus (T2DM) and premature cardiovascular disease. Subpopulations of high-density lipoprotein (HDL) have been associated with increased cardiovascular risk, but HDL composition, size, or function have not been studied in Indigenous Australians.

Methods: The study consisted of 86 non-Indigenous participants, 43 of whom had T2DM, and 75 Indigenous participants, 36 of whom had T2DM.

View Article and Find Full Text PDF

Background:  Traveling has become an important part of Saudi people's lives. Those diagnosed with type 2 diabetes mellitus (T2DM) encounter various challenges during travel that can adversely affect glycemic control. Studies have highlighted critical gaps in the knowledge, attitudes, and practices (KAP) of family medicine physicians in Saudi Arabia regarding pre-travel counseling for patients with type 2 diabetes.

View Article and Find Full Text PDF

Background: Data on the use of glucagon-like peptide-1 receptor agonists (GLP-1RAs) in individuals with type 2 diabetes mellitus (T2DM) during Ramadan fasting is limited. No meta-analysis has summarized the safety and effectiveness of GLP-1RAs in these situations.

Aim: To evaluate the safety and efficacy of GLP-1RA in patients with T2DM fasting during Ramadan.

View Article and Find Full Text PDF